Abstract
We have analyzed K-ras mutations and p53 alterations in 39 tumor and nontumor samples taken from nine patients with longstanding ulcerative colitis and colorectal carcinoma. Two of nine invasive carcinomas contained a K-ras mutation. By a combination of immunohistochemistry and single-strand conformation polymorphism analysis, p53 alterations were found in three of nine carcinomas. Five of 13 dysplastic lesions harbored a mutated K-ras gene, even in the absence of detectable changes in associated invasive tumors. One single focus of dysplastic mucosa harbored concomitant K-ras and p53 gene alterations. In two patients, a K-ras mutation was detected in epithelial lesions considered to be devoid of malignant potential (villous regeneration, active colitis). Our results indicate that: 1) the prevalence of K-ras and p53 genetic alterations found in ulcerative colitis-associated colonic carcinomas appears to be lower than in sporadic carcinomas; 2) K-ras mutations can be detected in dysplasia, villous regeneration, and active colitis and affect a subpopulation of the cells composing the lesions; 3) diverse genetic alterations can be detected in the same patient and the dysplastic lesions can exhibit a different genotype than the carcinomas; and 4) at least part of active colitis and villous regeneration lesions should be considered as preneoplastic in ulcerative colitis.
MeSH Terms
Adult
Aged
Base Sequence
Carcinoma/etiology,metabolism,pathology
Colitis, Ulcerative/complications,metabolism,pathology
Colorectal Neoplasms/etiology,metabolism,pathology
Female
Humans
Immunoenzyme Techniques
Male
Middle Aged
Molecular Sequence Data
Mutation
Oncogene Protein p21(ras)/genetics,metabolism
Polymerase Chain Reaction
Tumor Suppressor Protein p53/genetics,metabolism
Chemicals
Tumor Suppressor Protein p53
Oncogene Protein p21(ras)
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Chaubert P
Institut Universitaire de Pathologie, Lausanne, Switzerland.
Benhattar J
Saraga E
Costa J
References (27)
27 references, click to expand
-
The unlabeled antibody enzyme method of immunohistochemistry: preparation and properties of soluble antigen-antibody complex (horseradish peroxidase-antihorseradish peroxidase) and its use in identification of spirochetes.
J Histochem Cytochem. 1970 May;18(5):315-33
PMID: 4192899
-
Mammary origin of metastases. Immunohistochemical determination.
Arch Pathol Lab Med. 1992 Nov;116(11):1181-8
PMID: 1444749
-
Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications.
Hum Pathol. 1983 Nov;14(11):931-68
PMID: 6629368
-
Villous dysplasia. An ominous histologic sign in colitic patients.
Dis Colon Rectum. 1984 May;27(5):283-7
PMID: 6714042
-
Villous regeneration in ulcerative colitis.
Arch Pathol Lab Med. 1987 Mar;111(3):276-8
PMID: 3827532
-
Prevalence of ras gene mutations in human colorectal cancers.
Nature. 1987 May 28-Jun 3;327(6120):293-7
PMID: 3587348
-
Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms.
Proc Natl Acad Sci U S A. 1989 Apr;86(8):2766-70
PMID: 2565038
-
Activation of c-Ki-ras in human gastrointestinal dysplasias determined by direct sequencing of polymerase chain reaction products.
Cancer Res. 1990 Jun 15;50(12):3627-30
PMID: 2187599
-
A genetic model for colorectal tumorigenesis.
Cell. 1990 Jun 1;61(5):759-67
PMID: 2188735
-
c-Ki-ras mutations in chronic ulcerative colitis and sporadic colon carcinoma.
Gastroenterology. 1990 Aug;99(2):416-20
PMID: 2194896
-
p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis.
Cancer Res. 1990 Dec 1;50(23):7717-22
PMID: 2253215
-
Constitutional mutation in exon 8 of the p53 gene in a patient with multiple primary tumours: molecular and immunohistochemical findings.
Oncogene. 1993 May;8(5):1269-76
PMID: 8479749
-
p53 point mutations in dysplastic and cancerous ulcerative colitis lesions.
Gastroenterology. 1993 Jun;104(6):1633-9
PMID: 8500720
-
Accumulation of wild type p53 protein in human astrocytomas.
Cancer Res. 1993 Aug 1;53(15):3465-7
PMID: 8339248
-
Construction of T-vectors, a rapid and general system for direct cloning of unmodified PCR products.
Nucleic Acids Res. 1991 Mar 11;19(5):1154
PMID: 2020552
-
Frequent loss of a p53 allele in carcinomas and their precursors in ulcerative colitis.
Cancer Commun. 1991 Jun;3(6):167-72
PMID: 2049225
-
p53 mutations in human cancers.
Science. 1991 Jul 5;253(5015):49-53
PMID: 1905840
-
c-Ki-ras gene mutations in dysplasia and carcinomas complicating ulcerative colitis.
Br J Cancer. 1991 Jul;64(1):174-8
PMID: 1854618
-
Protocols for an improved detection of point mutations by SSCP.
Nucleic Acids Res. 1991 Jul 25;19(14):4009
PMID: 1650461
-
Simplified procedures for applying the polymerase chain reaction to routinely fixed paraffin wax sections.
J Clin Pathol. 1991 Feb;44(2):115-8
PMID: 1650795
-
Occurrence of Ki-ras and p53 mutations in primary colorectal tumors.
Oncogene. 1991 Nov;6(11):2121-8
PMID: 1945416
-
Loss of heterozygosity affecting the p53, Rb, and mcc/apc tumor suppressor gene loci in dysplastic and cancerous ulcerative colitis.
Cancer Res. 1992 Feb 1;52(3):741-5
PMID: 1346256
-
c-Ki-ras mutations in dysplastic fields and cancers in ulcerative colitis.
Gastroenterology. 1992 Jun;102(6):1983-7
PMID: 1350261
-
Stability of K-ras mutations throughout the natural history of human colorectal cancer.
Eur J Cancer. 1992;28A(6-7):1115-20
PMID: 1627381
-
Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion.
Proc Natl Acad Sci U S A. 1992 Aug 1;89(15):7262-6
PMID: 1353891
-
Neoplastic progression in ulcerative colitis: histology, DNA content, and loss of a p53 allele.
Gastroenterology. 1992 Nov;103(5):1602-10
PMID: 1358743
-
Cancer in colitis: assessment of the individual risk by clinical and histological criteria.
Gastroenterology. 1977 Dec;73(6):1280-9
PMID: 913969